Carisma Therapeutics | 3:首次持股声明-董事 Cheng Sohanya Roshan
Carisma Therapeutics | 4:持股变动声明-董事 Cheng Sohanya Roshan
Carisma Therapeutics | 4:持股变动声明-董事 Thorell Marella
Carisma Therapeutics | 4:持股变动声明-董事 Scadden David
Carisma Therapeutics | 3:首次持股声明-董事 Thorell Marella
Carisma Therapeutics | 3:首次持股声明-董事 Scadden David
Carisma Therapeutics | 4:持股变动声明-董事 ZWEIFACH SANFORD S
Carisma Therapeutics | 4:持股变动声明-董事 Morrison Briggs
Carisma Therapeutics | 4:持股变动声明-董事 Hohneker John
Carisma Therapeutics | 4:持股变动声明-董事 Torok Michael
Carisma Therapeutics | 4:持股变动声明-高管 Morris Richard Steven
Carisma Therapeutics | 4:持股变动声明-高管 Klichinsky Michael
Carisma Therapeutics | 4:持股变动声明-高管 Kelly Steven
Carisma Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-HealthCap VII, L.P.(8.2%),HealthCap VII GP LLC(8.2%)
Carisma Therapeutics | 4:持股变动声明-董事 Hohneker John
Carisma Therapeutics | 3:首次持股声明-董事 Hohneker John
Carisma Therapeutics | SC 13G:超过5%持股股东披露文件-AbbVie Biotechnology Ltd.(6.8%)
Carisma Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-HealthCap VII, L.P.(8.4%),HealthCap VII GP LLC(8.4%)
Carisma Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(3.89%)
Carisma Therapeutics | 4:持股变动声明-高管 Kelly Steven